Safety and efficacy of atorvastatin vs. colestipol in children and adolescents with Familial Hypercholesterolemia

被引:0
|
作者
Muñoz, MT
Alonso, M
Oyarzabal, M
Mainou, C
Fabiani, F
Sol, JM
Gracia, R
Diaz, C
Hernandez, G
机构
[1] Hosp Nino Jesus, Madrid, Spain
[2] Hosp Ramon y Cajal, E-28034 Madrid, Spain
[3] Hosp Virgen Camino, Pamplona, Spain
[4] Hosp St Joan de Deu, Barcelona, Spain
[5] Hosp Virgen Macarena, Seville, Spain
[6] Pfizer, Barcelona, Spain
[7] Euroclin Inst, Barcelona, Spain
[8] Pfizer, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3132
引用
收藏
页码:689 / 689
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolemia
    Van der Graaf, A.
    Nierman, M. C.
    Firth, J. C.
    Wolmarans, K. H.
    Marais, A. D.
    De Groot, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 585 - 585
  • [2] COMPARATIVE-STUDY OF COLESTIPOL AND COLESTYRAMINE IN CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    MORDASINI, R
    TWELSICK, F
    OSTER, P
    SCHELLENBERG, B
    RAETZER, H
    HEUCK, CC
    SCHLIERF, G
    MONATSSCHRIFT KINDERHEILKUNDE, 1978, 126 (07) : 436 - 440
  • [3] Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe
    Harada-Shiba, Mariko
    Kastelein, John J. P.
    Hovingh, G. Kees
    Ray, Kausik K.
    Ohtake, Akira
    Arisaka, Osamu
    Ohta, Takao
    Okada, Tomoo
    Suganami, Hideki
    Wiegman, Albert
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (05) : 422 - 429
  • [4] Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: A multicenter, randomized, placebo-controlled trial
    McCrindle, BW
    Ose, L
    Marais, AD
    JOURNAL OF PEDIATRICS, 2003, 143 (01): : 74 - 80
  • [5] LOW-DOSE COLESTIPOL IN CHILDREN, ADOLESCENTS AND YOUNG-ADULTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    SCHLIERF, G
    MROZIK, K
    HEUCK, CC
    MIDDELHOFF, G
    OSTER, P
    RIESEN, W
    SCHELLENBERG, B
    ATHEROSCLEROSIS, 1982, 41 (01) : 133 - 138
  • [6] Efficacy and safety of simvastatin in children with familial hypercholesterolemia
    de Jongh, S
    Ose, L
    Szamosi, T
    Tuohy, MB
    Stepanavage, M
    Sapre, A
    Gumbiner, B
    Mercuri, M
    van Trotsenburg, ASP
    Bakker, HD
    Kastelein, JJ
    CIRCULATION, 2002, 106 (19) : 74 - 74
  • [7] PHARMACOGENETIC PROFILE OF LIPID RESPONSE TO ATORVASTATIN IN CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Manolopoulos, V. G.
    Drogari, E.
    Ragia, G.
    Mollaki, V.
    Elens, L.
    Van Schaik, R. H. N.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E6 - E7
  • [8] An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia
    Gandelman, Kuan
    Glue, Paul
    Laskey, Rachel
    Jones, Jonathan
    LaBadie, Robert
    Ose, Leiv
    PEDIATRIC CARDIOLOGY, 2011, 32 (04) : 433 - 441
  • [9] An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia
    Kuan Gandelman
    Paul Glue
    Rachel Laskey
    Jonathan Jones
    Robert LaBadie
    Leiv Ose
    Pediatric Cardiology, 2011, 32 : 433 - 441
  • [10] Efficacy and safety of combination torcetrapib/atorvastatin versus atorvastatin alone in patients with heterozygous familial hypercholesterolemia
    Revkin, James
    Ose, Leiv
    Marais, A. David
    Pretorius, Matty
    Viljoen, Johann
    Burgess, Lesley
    Lan, Shu-Ping
    Thuren, Tom
    Shear, Charles
    CIRCULATION, 2006, 114 (18) : 318 - 318